Search - tctmd.com

Displaying 661 - 680 of 1588

Sort: Relevancy | Date

Presentation TCT 2019

MAGSTEMI: A Randomized Trial of a Magnesium-Based Sirolimus-Eluting Resorbable Scaffold vs. Metallic DES in Patients With STEMI

Presenter: Manel Sabate

September 27, 2019

Presentation TCT 2019

PROTECCT: A Randomized Trial of Emergency CTA in Patients With Possible ACS and Intermediate Levels of HS-Troponin Elevation

Presenter: Divaka Perera

September 27, 2019

Presentation TCT 2019

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

Presenter: Anthony Gershlick

September 27, 2019

Presentation TCT 2019

CIT-RESOLVE: A Randomized Trial of Sidebranch Protection in Patients With Coronary Bifurcations and High Predicted Risk of Sidebranch Occlusion

Presenter: Bo Xu

September 27, 2019

Presentation TCT 2019

Industry Perspectives on Controlled Trials for Shock Devices

Presenter: Seth Bilazarian

September 27, 2019

Presentation TCT 2019

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

Presenter: Bernardo Cortese

September 27, 2019

Presentation TCT 2019

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

Presenter: Marianne Brodmann

September 27, 2019

Presentation TCT 2019

Industry View on Controlled Trials for Heart Failure and Shock Devices

Presenter: William Abraham

September 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

Presentation TCT 2019

Devices for Heart Failure: FDA Perspectives on Trial Designs and Endpoints

Presenter: Bram Zuckerman

September 27, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

Answers and Questions After AUGUSTUS

Presenter: C. Michael Gibson

September 27, 2019

Presentation TCT 2019

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

Balancing Efficacy and Safety in Trial Interpretation

Presenter: David Cohen

September 27, 2019

Presentation TCT 2019

Drug-Coated Balloons in the Periphery: Red Alert or Red Herring?

Presenter: Eric Secemsky

September 27, 2019

News Conference News TCT 2019

Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint

Todd Neale

September 27, 2019

Presentation TCT 2019

When the Primary Endpoint Is Missed: The CABANA Case Study

Presenter: Bernard Gersh

September 27, 2019

Presentation TCT 2019

Alternatives to Intention to Treat Analysis: Can They Be Trusted?

Presenter: Stuart Pocock

September 27, 2019

Innovation Gone Wild - Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presentation TCT 2019

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presenter: Tamim Nazif

September 27, 2019

Presentation TCT 2019

Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoro-Popliteal Occlusive Disease: 3-Year Clinical and Ambulatory Outcome

Presenter: Piotr Buszman

September 27, 2019

Advertisement

MAGSTEMI: A Randomized Trial of a Magnesium-Based Sirolimus-Eluting Resorbable Scaffold vs. Metallic DES in Patients With STEMI

PROTECCT: A Randomized Trial of Emergency CTA in Patients With Possible ACS and Intermediate Levels of HS-Troponin Elevation

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

CIT-RESOLVE: A Randomized Trial of Sidebranch Protection in Patients With Coronary Bifurcations and High Predicted Risk of Sidebranch Occlusion

Industry Perspectives on Controlled Trials for Shock Devices

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

Industry View on Controlled Trials for Heart Failure and Shock Devices

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Devices for Heart Failure: FDA Perspectives on Trial Designs and Endpoints

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Answers and Questions After AUGUSTUS

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Balancing Efficacy and Safety in Trial Interpretation

Drug-Coated Balloons in the Periphery: Red Alert or Red Herring?

Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint

When the Primary Endpoint Is Missed: The CABANA Case Study

Alternatives to Intention to Treat Analysis: Can They Be Trusted?

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoro-Popliteal Occlusive Disease: 3-Year Clinical and Ambulatory Outcome

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content